2017 SPRING - If data is the currency of R&D, how do we recognize its value?
DATE, LOCATION & HOST
SPRING 2017 TECH MEETING
Meeting hosted by Bayer AG
If data is the currency of R&D, how do we recognise its value?
Analysis and visualization of internal and externally hosted data is critical to the on-going success of Pharma R&D as it searches for patterns, trends and sequences in the R&D processes to discover, develop and bring to market new drugs for unmet patient needs.
Data is the key currency for bio-pharmaceutical R&D. R&D generates, consumes, analyses and represents data for operational purposes as well as generating insights. The processes of R&D are data driven and should be clearly understood to provide clarity about the data backing the science and claims being made for medicines.
The importance of data provenance, governance, curation, sharing and tracking should be a cultural norm for all scientists within R&D. In the rush to new scientific advances, concerns of data management, controls and processes are sometimes viewed as of secondary importance. Data without context is not useful and if used to make decisions, damaging. As the body of data grows, how does one understand and interpret how much governance is ‘good enough’?
Data analytics is a continuing strategic theme for the biopharmaceutical sector as the industry is faced with an explosion of biomedical data being generated and made available for R&D use. Along with the increasing volumes of publicly available data, new entrants have been observed in the life science industry, including non-traditional companies such as Facebook, Amazon and Google. How will the biopharmaceutical industry ensure that these new and exciting technologies will process these data intelligently?
Advances in data analytics do not appear to have reduced the effort required to prepare the data for use. A recent survey of data scientists suggests that data preparation is the most time consuming and least enjoyable aspect of their jobs. As the volumes and variety of data increase, the veracity, provenance, integrity – indeed the simple ‘usefulness’ of data becomes increasingly difficult to assess.
The focus of this PRISME forum Technical Meeting will be to explore classic and modern techniques and technologies that will aid biopharma R&D in collating, organizing, filtering, preparing and sharing data to provide the best opportunities to our scientists and operations in generating further value from our data – not least by collaboration.
A PRISME Forum Technical Meeting Advisory Committee (TMAC) has been established to provide guidance on agenda topics and appropriately qualified speakers. The committee members are listed below:
|Technical Meeting Advisory Committee Spring 2017|
|6.||Jim McGurk||Daiichi Sankyo|
|11.||Dan Chapman (Chairman)||UCB|
The PRISME Forum Technical Meeting Advisory Committee will be looking for qualified speakers to address relevant topics including:
- New technologies enabling new ways of managing data relevant to bio-pharma R&D
- Emerging trends in biopharma R&D / Healthcare IT data management and analytics investment
- Data aggregation, distillation and visualization – including ‘omics’ and Real World Evidence
- Knowledge management approaches including computational linguistics
- Cross-company collaboration technologies
Reeve - PRISME May 2017 - The Data Catalog
AETIONOMY talk PRISME Forum Berlin May 2017
Prisme Poster Final_EDETEK
SciBite A0 Poster_PRINT
2017 PRISME poster gross
Abbott - RWD in Early Development
Rates are valid ONLY through April 17, 2017. Cancellations made after April 24 may incur a penalty fee of 90% of the individual reservation amount (if needing to cancel a reservation, please reach out to both, the hotel as well as PRISME Forum secretariat).
Reservations can be made by phone, fax or email:
tel +49 30 22010 2260
fax: +49 30 22010 2222
When reserving a room, please remember to use “PRISME” for the above rate and appropriate allocation to our room block.
DISTANCE TO MEETING VENUE FROM THE AIRPORT
Berlin Schönefeld Airport (IATA: SXF) is a 40 minute ride (25 km) from the meeting venue and a 30 minutes transfer from the conference hotel (Swissotel Berlin).